Results 231 to 240 of about 351,954 (346)

A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma

Haematologica, 2014
Neha Korde, Mattias Carlsten, Min-Jung Lee, Alex Minter, Esther Tan, Mary Kwok, Elisabet Manasanch, Manisha Bhutani, Nishant Tageja, Mark Roschewski, Adriana Zingone, Rene Costello, Marcia Mulquin, Diamond Zuchlinski, Irina Maric, Katherine R. Calvo, Raul Braylan, Prashant Tembhare, Constance Yuan, Maryalice Stetler-Stevenson, Jane Trepel, Richard Childs, Ola Landgren   +22 more
doaj   +1 more source

Identification of Potential Ferroptosis Biomarkers in Multiple Myeloma via WGCNA and Experiments. [PDF]

Cancer Rep (Hoboken)
Wang Y, Xie X, Gu M, Zheng Y, Wu J, Wang Q, Ling Z, Li R.   +7 more
europepmc   +1 more source

Cancer-selective targeting of the NF-κB pathway via GADD45β/MKK7 inhibition: Results from the phase I trial of the first-in-class inhibitor, DTP3, in patients with relapsed or refractory multiple myeloma [PDF]

Aristeidis Chaidos, Dimitrios Potolidis, Jessica Cornice, Holger W. Auner, Gary D Acton, Ceri Bygrave, Gordon Cook, Rakesh Popat, Andrew Davies, Christopher Parrish, Maria Atta, Kim Linton, Dean Smith, Christopher P. Fox, Iain A. McNeish, Elizabeth Hadley, Erika Peral, Mario Pellegatti, Nigel Adams, Albert Chau, Precious Nnebedum, Daria Capece, Daniela Verzella, Daniel D’Andrea, Jan Rekowski, Christina Yap, Laura Tornatore, Guido Franzoso   +27 more
openalex   +1 more source

Importance of SUMOylation Consensus Sequence of MAFK in Regulating EMT, Tumor Growth, Stemness, and Drug Resistance

Cancer Science, EarlyView.
In this study, we focused on SUMOylation, a posttranslational modification, and investigated the importance of its consensus sequence in MAFK. We demonstrated that the non‐SUMOylation mimic mutant MAFK (EA) impairs MAFK‐induced EMT, cellular migration and invasion, tumor and sphere formation, acquisition of stem‐like properties, and drug resistance ...
Thuy Linh Dang Cao, Yukari Okita, Reon Yahatabara, Manar A. Elhinnawi, Nuriza Ulul Azmi, Thanasis Poullikkas, Hozumi Motohashi, Mitsuyasu Kato   +7 more
wiley   +1 more source

Tocilizumab prophylaxis for patients with multiple myeloma treated with bispecific antibodies. [PDF]

Blood Adv
Kowalski A, Lykon J, Diamond B, Coffey D, Kaddoura M, Maura F, Hoffman J, Pandey A, Kazandjian D, Landgren O.   +9 more
europepmc   +1 more source

Defining mechanisms of NK cell dysfunction in the multiple myeloma tumor microenvironment 9377 [PDF]

Sadia Afrin, Todd A. Fehniger
openalex   +1 more source

PSMD12 Overexpression Promotes Lung Adenocarcinoma Progression via Ubiquitin–Proteasome Pathway Dysregulation

Cancer Science, EarlyView.
PSMD12, located on the frequently amplified 17q region in LUAD, is upregulated in tumors and associated with poor prognosis and advanced stage. Functional studies revealed that PSMD12 promotes cell proliferation and G2/M transition by inhibiting CDK1 ubiquitination and stabilizing CDK1.
Yuya Ono, Hajime Otsu, Takaaki Masuda, Keisuke Kosai, Shohei Shibuta, Kosuke Hirose, Takashi Ofuchi, Yuki Ando, Koto Kawata, Yasuo Tsuda, Yusuke Yonemura, Taro Tobo, Tomoyoshi Takenaka, Tomoharu Yoshizumi, Koshi Mimori   +14 more
wiley   +1 more source

Targeting of SKP2 to combat drug resistance in multiple myeloma. [PDF]

Sci Rep
Faruq O, Ngo J, Iyer D, Nesson J, Shrestha M, Chang H.   +5 more
europepmc   +1 more source

Targeted Capture and Sequencing of Immunoglobulin Rearrangements in Multiple Myeloma to Enable Detection of Minimal Residual Disease

, 2017
Signy Chow
openalex   +1 more source

SECURE study: Incidentally detected MGUS patients have comparable depression and anxiety rates to UK general population

British Journal of Haematology, EarlyView.
Elizabeth S. Knight, Sherin Varghese, Constantinos Koshiaris, Sulgi Byun, Richard Brouwer, Sæmundur Rögnvaldsson, Guy Pratt, Stella Bowcock, Ross Sadler, Aimee Maloney, Vicki M. Gamble, Roderick Oakes, Grace Killingsworth, Patricia Nicholls, Supratik Basu, Jacqueline Stones, Earnest Heartin, Victoria Garvey, Sarah J. Essex, Saranne Hufton, Karthik Ramasamy   +20 more
wiley   +1 more source